HIGHLIGHTS
- who: Santiago Bullich from the Life Molecular Imaging GmbH, Berlin, Germany have published the research work: Evaluation of tau deposition using, in the Journal: (JOURNAL)
- what: The aim of this work was to evaluate tau deposition using F-PI-2620 PET in beta-amyloid positive subjects with a diagnosis of mild cognitive impairment (MCI) or mild AD dementia and characterize it with respect to amyloid deposition cerebrospinal fluid (CSF) assessment hippocampal volume and cognition. This work has characterized the tau deposition using 18F-PI-2620 PET tracer in the early stages of the AD continuum . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.